AstraZeneca CEO says new global trial on COVID-19 vaccine likely November 26, 2020 AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine candidate, the company's CEO tells Bloomberg. Labels: CBC | Health News health Share to: Twitter Facebook URL Print Email
Post a Comment
EmoticonClick to see the code!
To insert emoticon you must added at least one space before the code.